Long-term consumption of vitamin E supplements may reduce the risk of developing amyotrophic lateral sclerosis (ALS)—known as Lou Gehrig’s disease, according to American Journal of Epidemiology. A research team from Harvard University pooled information from the Nurses' Health Study (1976-2004), the Health Professionals Follow-up Study (1986-2004), the Cancer Prevention Study II Nutrition Cohort (1992-2004), the Multiethnic Cohort Study (1993-2005), and the National Institutes of Health-AARP Diet and Health Study (1995-2005).
Out of 1,055,546 participants, 805 developed ALS. Duration of vitamin E supplement use showed ALS rates declined with increasing years of supplement use. Compared with non-users, the multivariable adjusted relative risk was 1.05 among users of less than one year; 0.77 among those subjects using vitamin E supplements for two to four years; and 0.64 among people taking vitamin E supplements for more than five years. The benefit persisted even after adjusting for other lifestyle factors such as weight, smoking habits, diet and exercise.
Alzheimer'sA combination of different vitamin E forms could help prevent cognitive deterioration in advanced age, according to the results of a study published Journal of Alzheimer's Disease. The findings suggest that it is multiple components of the vitamin that could reduce the risk of developing Alzheimer’s. The population-based study aimed to evaluate whether higher plasma levels of vitamin E could be protective against Alzheimer’s in advanced age and whether the protective activity could be due to more than just the tocopherol form of the vitamin.
Vitamin E is a family of eight natural components, but most studies related to Alzheimer's disease investigate only one of these components – alpha tocopherol. The researchers hypothesized that all the vitamin E components could be important in protecting against AD than one alone.
At the start of the study, all participants were dementia-free. After six years, subjects with higher blood levels of all the vitamin E family forms had a reduced risk of developing AD, compared to subjects with lower levels. After adjusting for various confounders, the risk was reduced by 45-54 percent, depending on the vitamin E component.
Steve - elderly people as a group are large consumers of vitamin E supplements, which usually contain only alpha tocopherol, and this often at high doses. We have said for years that a balanced presence of different vitamin E forms (mixed tocopherols) can have an important neuroprotective effect. However, almost all of the research done on vitamin E has included just the one component, alpha tocopherol. For vitamin E to function therapeutically, except for a multivitamin, it should be provided in its full spectrum state.
Consuming more vitamin E through the diet also appears to be associated with a lower risk of dementia and Alzheimer's disease, according to Archives of Neurology. Oxidative stress, damage to the cells from oxygen exposure, is thought to play a role in the development of Alzheimer's disease. One-third of individuals who consumed the most vitamin E were 25 percent less likely to develop dementia than the one-third of participants who consumed the least.
NAFLD
Vitamin E was found to mitigate the more progressive form of nonalcoholic fatty liver disease (NAFLD), reported in the Journal of the American Medical Association. The data suggests that children treated with vitamin E who had biopsy-proven nonalcoholic steatohepatitis (NASH) had significant improvement in secondary histologic outcomes with vitamin E. NAFLD has become the most common cause of chronic liver disease in children in the U.S.
No comments:
Post a Comment